|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 6 of 62 found articles
| Title: |
Bevacizumab in EGFR-positive NSCLC: time to change first-line treatment? |
| Author: |
Yang, James Chih-Hsin |
| Appeared in: |
Lancet oncology |
| Paging: | Volume 20 (2019) nr. 5 pages 602-603 |
| Year: |
2019 |
| Contents: | |
| Publisher: |
Elsevier Ltd |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 6 of 62 found articles
| << previous | next >> |